MAYNF Stock Mayne Pharma (MAYNF, $2.7) dropped -17.81% over the last 3 months

GET DAILY SIGNALS

Get AI intraday signals

MAYNF - Mayne Pharma Ltd.

Loading...

Price: $2.7

Daily change: -$1.1 (-28.95%)

Daily volume: 200

3-month price change: -$0.585 (-17.81%)

Capitalization: $234.6M

Industry: Pharmaceuticals: Major

Mayne Pharma (MAYNF, $2.7) lost -1 over the last three months. By comparison, the broader Pharmaceuticals: Major Industry returned over the same period. A.I.dvisor analyzed 62 stocks in the Pharmaceuticals: Major Industry over the last three months, and found that of them (5) exhibited an Uptrend while of them (4) experienced a Downtrend.

MAYNF in downward trend: price may drop because broke its higher Bollinger Band on November 19, 2025

MAYNF broke above its upper Bollinger Band on November 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Technical Analysis (Indicators)

Bearish Trend Analysis

MAYNF moved below its 50-day moving average on November 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for MAYNF entered a downward trend on December 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on December 11, 2025. You may want to consider a long position or call options on MAYNF as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MAYNF just turned positive on December 12, 2025. Looking at past instances where MAYNF's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.773) is normal, around the industry mean (9.032). MAYNF has a moderately low P/E Ratio (0.000) as compared to the industry average of (24.406). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.056). MAYNF's Dividend Yield (0.000) is considerably lower than the industry average of (0.026). P/S Ratio (0.686) is also within normal values, averaging (3.754).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MAYNF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.